Simplex Trading, LLC Puma Biotechnology, Inc. Transaction History

Simplex Trading, LLC

$3.28 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$2.92 - $5.83 $7,448 - $14,872	2,551 Added 269.38%	3,498 $11,000
Q1 2024 Apr 25, 2024	SELL	$4.29 - $7.4 $20,840 - $35,949	-4,858 Reduced 83.69%	947 $5,000
Q4 2023 Feb 02, 2024	BUY	$2.23 - $4.49 $11,257 - $22,665	5,048 Added 666.84%	5,805 $25,000
Q3 2023 Nov 01, 2023	SELL	$2.63 - $4.09 $12,079 - $18,785	-4,593 Reduced 85.85%	757 $1,000
Q2 2023 Aug 04, 2023	SELL	$2.6 - $3.58 $13,044 - $17,960	-5,017 Reduced 48.39%	5,350 $18,000
Q1 2023 Apr 27, 2023	BUY	$2.21 - $4.82 $22,911 - $49,968	10,367 New	10,367 $32,000
Q3 2022 Nov 04, 2022	BUY	$2.27 - $3.84 $28,336 - $47,934	12,483 Added 360.47%	15,946 $37,000
Q2 2022 Aug 03, 2022	BUY	$1.64 - $3.3 $5,679 - $11,427	3,463 New	3,463 $9,000
Q1 2022 May 02, 2022	SELL	$2.13 - $3.24 $167,230 - $254,378	-78,512 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$2.85 - $6.58 $216,229 - $499,224	75,870 Added 2871.69%	78,512 $238,000
Q2 2021 Aug 12, 2021	BUY	$8.98 - $11.6 $23,725 - $30,647	2,642 New	2,642 $24,000
Q2 2020 Jul 13, 2020	SELL	$7.01 - $13.24 $98,413 - $185,876	-14,039 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$6.28 - $14.57 $361,797 - $839,392	-57,611 Reduced 80.41%	14,039 $118,000
Q4 2019 Feb 05, 2020	BUY	$6.5 - $10.73 $443,579 - $732,247	68,243 Added 2003.02%	71,650 $626,000
Q3 2019 Oct 15, 2019	SELL	$8.75 - $12.85 $85,015 - $124,850	-9,716 Reduced 74.04%	3,407 $36,000
Q2 2019 Jul 26, 2019	BUY	$12.3 - $35.76 $62,631 - $182,089	5,092 Added 63.4%	13,123 $166,000
Q1 2019 Apr 18, 2019	SELL	$20.77 - $42.37 $554,247 - $1.13 Million	-26,685 Reduced 76.87%	8,031 $0
Q4 2018 Jan 16, 2019	BUY	$20.07 - $46.7 $563,645 - $1.31 Million	28,084 Added 423.46%	34,716 $706,000
Q3 2018 Oct 23, 2018	SELL	$41.2 - $59.85 $494,276 - $718,020	-11,997 Reduced 64.4%	6,632 $304,000
Q2 2018 Jul 30, 2018	BUY	$48.3 - $68.25 $899,780 - $1.27 Million	18,629 New	18,629 $1.1 Million
Q1 2018 Apr 26, 2018	SELL	$59.7 - $99.25 $202,681 - $336,953	-3,395 Closed	0 $0
Q4 2017 Jan 10, 2018	BUY	$93.85 - $132.45 $318,620 - $449,667	3,395	3,395 $335,000

Others Institutions Holding PBYI

# of Institutions

107

Shares Held

32.2M

Call Options Held

43.4K

Put Options Held

3.7K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$10.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$10.2 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.06M
Shares

$8.76 Million
0.42% of portfolio
Acorn Capital Advisors, LLC New York, NY

2.45M
Shares

$7.01 Million
6.49% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$5.64 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $130M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account